Medical Training AIGLP-1 Agonists in Aesthetic Practice
You'll be able to evaluate candidates for GLP-1 therapy in an aesthetic practice and discuss how weight management interacts with body contouring plans.
What this track covers
This track covers the pharmacology of semaglutide and other GLP-1 receptor agonists, including their effects on appetite regulation, gastric emptying, and insulin sensitivity. It addresses patient selection, contraindications, and how weight change can affect the timing and outcomes of aesthetic procedures.
What you will practice
- Distinguish semaglutide from tirzepatide by mechanism and receptor targets
- Screen patients for contraindications before considering GLP-1 therapy
- Explain gradual titration and why it affects tolerability
- Assess how active weight loss might influence body contouring timing
- Identify red flags that warrant referral rather than continued management
Simulator scenario
A virtual patient on a GLP-1 agonist presents for a body contouring consultation, and the clinician must assess readiness, screen for contraindications, and decide whether to proceed or defer.
Board question topics
- GLP-1 receptor mechanism of action
- Contraindications and precautions for GLP-1 agonists
- Differences between semaglutide and tirzepatide
- Patient assessment before combining weight management with aesthetic procedures
Ask the tutor
The tutor only answers from licensed sources (FDA prescribing information, public guidelines and our own material) and says when it has none. Educational use only, never patient-specific advice.
Free during the beta. Sign in with your email, no password.
Start free